Posts by admin
Getting Answers: Agawam exterminator takes part in Lyme disease vaccine trial for rodents
AGAWAM, Mass. (WGGB/WSHM) – The first Lyme disease vaccine licensed for mice has been approved by the U.S. Department of Agriculture to help prevent the disease’s spread and a local exterminator will be one of the first to give it a try. “People don’t realize that they are the largest mover of Lyme disease in…
Read MoreUTHSC Researcher’s Lyme Disease Intervention Headed to Market
On one wall in the modest office of Maria Gomes-Solecki, DVM, a professor in the Department of Microbiology, Immunology & Biochemistry at the University of Tennessee Health Science Center, hangs a framed letter that is the culmination of more than 20 years of work. Dated April 27, the letter is from the U.S. Department of…
Read MoreWhat you need to know to stay safe from ticks this summer
According to the Centers for Disease Control, as many as 476,000 people in the U.S. contract Lyme disease every year. Climate change and human encroachment into wilderness areas means ticks and the disease-causing bacteria they carry are becoming more common. Dr. Linden Hu, an immunology professor and co-director of the Lyme Disease Initiative at Tufts…
Read MoreUSDA green-lights Lyme disease vaccine that targets mice hosts
The US Department of Agriculture (USDA) has conditionally licensed an oral vaccine designed to limit the spread of Borrelia burgdorferi, the bacterium that causes Lyme disease. The vaccine is sprayed onto pellets and distributed in natural settings to be consumed by mice. Lyme disease is the nation’s most common vectorborne disease, and the US Centers…
Read MoreFirst Lyme Disease Vaccine Licensed for Mice
MEMPHIS (Precision Vaccinations) The U.S. Department of Agriculture recently issued a Conditional Licensure for a novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease. Announced by US Biologic, Inc. on May 9, 2023, this innovative Borrelia Burgdorferi Bacterin vaccine is spray-coated onto pellets that mice consume. As the expression goes, if you give a mouse a vaccine…..…
Read MoreUS Biologic Announces USDA Conditional Licensure of Oral Lyme Vaccine for Wildlife
MEMPHIS, Tenn. – US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announces USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S. The only known vector is the…
Read MoreMemphis-based US Biologic is ready to take a vaccine to market that could help the fight against Lyme disease
Let’s begin with a blacklegged tick. At the risk of anthropomorphizing, we’ll call him Hank. A fledgling tick, Hank is a larva, and to move into the next stage of his life cycle, a nymph, he needs a meal — specifically, a blood meal. So, young Hank, ever determined, latches on to a white-footed mouse —…
Read MoreUS Biologic Presents Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics
Dr. Jolieke G. van Oosterwijk, US Biologic Chief Scientific Officer, presented key findings on a chewable flu vaccine that US Biologic is developing in partnership with the Biomedical Advanced Research and Development Authority (BARDA) Division of Research, Innovation, and Ventures (DRIVe) as part of its Beyond the Needle program. The presentation was held at the…
Read MoreUS Biologic – A Breakthrough: Edible Vaccine in “Gummy” Form
Host Jeremy C. Park talks with Dr. Jolieke van Oosterwijk, Chief Scientific Officer with US Biologic, who highlights the Memphis-based company developing groundbreaking orally delivered vaccines, changing global disease prevention and allowing safe, effective, and cost-efficient delivery of preventative interventions to wildlife, companion animals, food animals, and humans. During the interview, Jolieke discusses how they…
Read MoreUS Biologic Presents at World Vaccine Congress
US Biologic’s CSO, Dr. Jolieke G. van Oosterwijk, presented at the World Vaccine Congress in Washington, D.C. Dr. van Oosterwijk discussed “using zoonotic disease surveillance to guide oral vaccine design” and presented the methods US Biologic uses to prevent pandemic-level diseases. In her talk, Dr. van Oosterwijk explained to the audience the unique nature of oral…
Read More